Candidate biomarkers for extra-articular involvement in RA were anti-Ro/SSA antibodies (an anti-extractable nuclear antigen antibody; ENA), and a high level of circulating immune complexes (22, 23). This evidence concerns the gene TRIM21 and rheumatoid arthritis.